Patterns and Implications of B-Type Natriuretic Peptide Measurement in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes††Conflicts of interest: L. Kristin Newby receives research grants from Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, the Schering Plough Research Institute ...

American Journal of Cardiology

Volumn 100, Issue 12, 2007, Pages 1727-1733

  Atwater, Brett D ^a   Milford Beland, Sarah ^b   Newby, L Kristin ^b   Hernandez, Adrian F ^b   Peacock, W Frank ^c   Gibler, W Brian ^d   Christenson, Robert H ^e   Ohman, E Magnus ^b   Peterson, Eric D ^b   Roe, Matthew T ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 36949005595     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.023     Document Type: Article

References (20)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
2. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 6 (2004) 257-260
3. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long term mortality in stable coronary disease. N Engl J Med 352 (2005) 666-673
4. Sadanandan S., Cannon C.P., Chekuri K., Murphy S.A., Dibattiste P.M., Morrow D.A., de Lemos J.A., Braunwald E., and Gibson C.M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
5. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
6. Morrow D.A., de Lemos J.A., Sabatine M.S., Murphy S.A., Demopoulos L.A., DiBattiste P.M., McCabe C.H., Gibson C.M., Cannon C.P., and Braunwald E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41 (2003) 1264-1272
7. Arakawa N., Nakamura M., Aoki H., and Hiramora K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 85 (1994) 334-340
8. Arakawa N., Nakamura M., Aoki H., and Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27 (1996) 1656-1661
9. Suzuki S., Yoshimura M., Nakayama M., Mizuno Y., Harada E., Ito T., Nakamura S., Abe K., Yamamuro M., Sakamoto T., et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction. Circulation 110 (2004) 1387-1391
10. Doust J., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
11. Bhatt D.L., Roe M.T., Peterson E.D., Li Y., Chen A.Y., Harrington R.A., Greenbaum A.B., Berger P.B., Cannon C.P., Cohen D.J., et al., CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE quality improvement initiative. JAMA 292 (2004) 2096-2104
12. Hoekstra J.W., Pollack Jr. C.V., Roe M.T., Peterson E.D., Brindis R., Harrington R.A., Christenson R.H., Smith S.C., Ohman E.M., and Gibler W.B. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med 9 (2002) 1146-1155
13. Palumbo B., Siepi D., Lupattelli G., Sinzinger H., Fiorucci G., Anniboletti P.F., Latini R.A., Mannarino E., and Palumbo R. Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol 94 (2004) 780-783
14. James S.K., Lindback J., Tilly J., Siegbahn A., Venge P., Armstrong P., Califf R., Simoons M.L., Wallentin L., and Lindahl B. Troponin-T and N-terminal pro-B type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol 48 (2006) 1146-1154
15. Newby L.K., Ohman E.M., Christenson R.H., Moliterno D.J., Harrington R.A., White H.D., Armstrong P.W., Van De Werf F., Pfisterer M., Hasselblad V., et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status. The PARAGON-B Troponin T substudy. Circulation 103 (2001) 2891-2896
16. Morrow D.A., Cannon C.P., Rifai N., Frey M.J., Vicari R., Lakkis N., Robertson D.H., Hille D.A., DeLucca P.T., DiBattiste P.M., et al., TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 286 (2001) 2405-2412
17. Jernberg T., Lindahl B., Siegbahn A., Andren B., Frostfeldt G., Lagerqvist B., Stridsberg M., Venge P., and Wallentin L. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 42 (2003) 1909-1916
18. Windhausen F., Hirsch A., Sanders G.T., Cornel J.H., Fischer J., van Straalen J.P., Tijssen J.G., Verheugt F.W., de Winter R.J., and Invasive Versus Conservative Treatment in Unstable Coronary Syndromes Investigators. N-terminal pro-B-type natriuretic peptide for additional risk stratification in patients with non ST elevation acute coronary syndromes and an elevated troponin T: an ICTUS substudy. Am Heart J 153 (2007) 485-492
19. de Lemos J.A., and Morrow D.A. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 153 (2007) 450-453
20. Roe M.T., Chen A.Y., Riba A.L., Goswami R.G., Peacock W.F., Pollack Jr. C.V., Collins S.P., Gibler W.B., Ohman E.M., Peterson E.D., and CRUSADE Investigators. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 97 (2006) 1707-1712